endocrine:glp1_gip_gra:triple_incretin_agonists
Differences
This shows you the differences between two versions of the page.
| endocrine:glp1_gip_gra:triple_incretin_agonists [2026/02/13 00:34] – created andrew2393cns | endocrine:glp1_gip_gra:triple_incretin_agonists [2026/02/13 00:34] (current) – [Investigational Agents] andrew2393cns | ||
|---|---|---|---|
| Line 61: | Line 61: | ||
| ===== Investigational Agents ===== | ===== Investigational Agents ===== | ||
| - | * Retatrutide | + | * [[endocrine: |
| Retatrutide is the most advanced triple incretin agonist in clinical development. | Retatrutide is the most advanced triple incretin agonist in clinical development. | ||
endocrine/glp1_gip_gra/triple_incretin_agonists.1770942848.txt.gz · Last modified: by andrew2393cns